Nifty
Sensex
:
:
13109.05
44833.17
140.10 (1.08%)
177.73 (0.40%)

Pharmaceuticals & Drugs - Domestic

Rating :
68/99

BSE: 500680 | NSE: PFIZER

5107.65
01-Dec-2020
  • Open
  • High
  • Low
  • Previous Close
  •  5145.00
  •  5154.05
  •  5085.00
  •  5104.50
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  40414
  •  2069.31
  •  5900.00
  •  3461.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 23,355.13
  • 46.91
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 21,137.76
  • 6.46%
  • 10.90

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 63.92%
  • 3.12%
  • 14.43%
  • FII
  • DII
  • Others
  • 1.93%
  • 14.62%
  • 1.98%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.56
  • 1.35
  • 3.01

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.84
  • 5.76
  • 2.73

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.44
  • 10.79
  • 12.24

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 33.13
  • 33.98
  • 34.20

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.46
  • 6.46
  • 6.46

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.67
  • 17.69
  • 19.14

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBITDA
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PBT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Tax
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Nov 08
Nov 07
Nov 06
Nov 05
Net Sales
-
736.83
736.57
736.33
674.84
Net Sales Growth
-
0.04%
0.03%
9.11%
 
Cost Of Goods Sold
-
195.94
190.88
186.99
189.67
Gross Profit
-
540.89
545.69
549.34
485.17
GP Margin
-
73.41%
74.09%
74.61%
71.89%
Total Expenditure
-
585.58
580.08
570.64
558.84
Power & Fuel Cost
-
7.17
7.94
7.50
7.96
% Of Sales
-
0.97%
1.08%
1.02%
1.18%
Employee Cost
-
98.43
98.71
100.37
98.57
% Of Sales
-
13.36%
13.40%
13.63%
14.61%
Manufacturing Exp.
-
92.14
85.84
85.45
80.87
% Of Sales
-
12.50%
11.65%
11.60%
11.98%
General & Admin Exp.
-
49.05
48.30
45.81
45.04
% Of Sales
-
6.66%
6.56%
6.22%
6.67%
Selling & Distn. Exp.
-
99.87
106.89
103.95
96.59
% Of Sales
-
13.55%
14.51%
14.12%
14.31%
Miscellaneous Exp.
-
42.98
41.51
40.57
40.15
% Of Sales
-
5.83%
5.64%
5.51%
5.95%
EBITDA
-
151.25
156.49
165.69
116.00
EBITDA Margin
-
20.53%
21.25%
22.50%
17.19%
Other Income
-
71.10
321.80
33.47
33.24
Interest
-
0.00
0.02
0.07
0.16
Depreciation
-
11.12
9.58
13.07
13.85
PBT
-
211.22
468.69
186.01
135.23
Tax
-
119.56
111.34
56.31
41.13
Tax Rate
-
28.53%
24.67%
34.62%
36.77%
PAT
-
299.57
340.00
106.33
70.73
PAT before Minority Interest
-
299.57
340.00
106.33
70.73
Minority Interest
-
0.00
0.00
0.00
0.00
PAT Margin
-
40.66%
46.16%
14.44%
10.48%
PAT Growth
-
-11.89%
219.76%
50.33%
 
EPS
-
65.55
74.40
23.27
15.48

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Nov 08
Nov 07
Nov 06
Nov 05
Shareholder's Funds
901.09
649.72
439.76
375.95
Share Capital
29.84
29.84
29.84
29.84
Total Reserves
871.25
619.88
409.91
346.11
Non-Current Liabilities
-22.67
-12.98
-14.36
-9.03
Secured Loans
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
Current Liabilities
926.36
820.65
696.33
623.95
Trade Payables
108.18
92.43
137.62
120.16
Other Current Liabilities
14.50
14.17
8.14
16.26
Short Term Borrowings
0.00
0.00
0.00
0.00
Short Term Provisions
803.68
714.05
550.57
487.53
Total Liabilities
1,804.78
1,457.39
1,121.73
990.87
Net Block
50.76
60.16
69.96
75.56
Gross Block
139.90
141.61
168.14
170.15
Accumulated Depreciation
89.14
81.45
98.19
94.59
Non Current Assets
83.56
70.91
71.56
77.71
Capital Work in Progress
32.30
10.24
1.60
2.14
Non Current Investment
0.50
0.50
0.00
0.00
Long Term Loans & Adv.
0.00
0.00
0.00
0.00
Other Non Current Assets
0.00
0.00
0.00
0.00
Current Assets
1,721.22
1,383.55
1,036.82
876.46
Current Investments
0.00
0.00
0.00
0.00
Inventories
124.99
95.85
99.31
90.71
Sundry Debtors
60.31
61.69
70.10
83.54
Cash & Bank
543.65
479.91
306.94
210.15
Other Current Assets
992.26
8.17
4.22
2.14
Short Term Loans & Adv.
977.77
737.92
556.25
489.92
Net Current Assets
794.86
562.90
340.50
252.52
Total Assets
1,804.78
1,457.39
1,121.72
990.87

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Nov 08
Nov 07
Nov 06
Nov 05
Cash From Operating Activity
237.76
16.63
123.19
102.74
PBT
211.22
468.69
186.01
135.23
Adjustment
-49.50
-298.40
-8.73
7.24
Changes in Working Capital
-7.89
-33.39
11.64
-2.41
Cash after chg. in Working capital
153.83
136.91
188.92
140.06
Interest Paid
0.00
0.00
0.00
0.00
Tax Paid
-126.90
-113.33
-65.74
-37.32
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
Cash From Investing Activity
-78.87
232.35
-47.99
-73.08
Net Fixed Assets
-20.35
17.89
2.55
Net Investments
0.00
-0.50
0.00
Others
-58.52
214.96
-50.54
Cash from Financing Activity
-95.20
-75.90
-33.82
-46.02
Net Cash Inflow / Outflow
63.69
173.09
41.38
-16.36
Opening Cash & Equivalents
479.91
306.83
10.00
26.36
Closing Cash & Equivalent
543.61
479.91
51.38
10.00

Financial Ratios

Standalone /

Consolidated
Description
Nov 08
Nov 07
Nov 06
Nov 05
Book Value (Rs.)
301.96
216.74
142.90
113.68
ROA
18.37%
26.37%
10.07%
9.39%
ROE
38.71%
63.36%
27.78%
22.90%
ROCE
54.15%
84.11%
42.50%
35.52%
Fixed Asset Turnover
5.62
5.16
4.71
4.43
Receivable days
28.15
30.12
35.19
39.05
Inventory Days
50.96
44.60
43.53
41.49
Payable days
69.16
84.39
92.33
80.44
Cash Conversion Cycle
9.95
-9.68
-13.61
0.09
Total Debt/Equity
0.00
0.00
0.00
0.00
Interest Cover
0.00
0.00
2275.76
712.58

News Update:


  • Pfizer modifies protocol for virus vaccine study
    13th Oct 2020, 11:52 AM

    The company has received permission from the Food and Drug Administration to include adolescents aged 12 through 15 in its global COVID-19 vaccine study

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.